Company Snapshot: SIPX  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Sipex Reports Second Quarter 2007 Financial Results

 - Second Quarter Net Sales of $18.4 Million, Up 9% from the First Quarter
               of 2007 and Down 12% From the Year-Ago Period
  - Second Quarter Gross Margin at 22%, Down from the First Quarter Gross
     Margin of 26% and Up from the Year-Ago Period Gross Margin of 18%
 - Second Quarter GAAP Net Loss of $8.0 Million, compared to a $6.3 Million
 Net Loss in the Prior Quarter and a $6.9 Million Net Loss in the Year-Ago
                                   Period
 - Company Anticipates Shareholder Approval of a Merger Agreement with Exar
   Corporation at its shareholders meeting scheduled for August 23, 2007.

    MILPITAS, Calif., Aug. 14 /PRNewswire-FirstCall/ -- Sipex Corporation
(Nasdaq: SIPX) reported today fiscal second quarter operating results. Net
Sales for the second quarter of 2007 were $18.4 million, up 9% from the
first quarter of 2007 net sales of $16.9 million and down 12% from net
sales of $21.0 million recorded in the year-ago period. Second quarter 2007
GAAP net loss was $8.0 million, or $0.42 per share, compared with GAAP net
loss of $6.3 million, or $0.34 per share, in the previous quarter and GAAP
net loss of $6.9 million, or $0.39 per share, in the year-ago period. The
second quarter 2007 GAAP net loss included stock-based compensation of $0.9
million, or $0.05 per share.
    Second quarter 2007 non-GAAP net loss was $7.2 million, or $0.38 per
share, compared to $5.3 million, or $0.29 per share, in the previous
quarter and compared to $6.1 million, or $0.34 per share in the second
quarter of 2006. Non-GAAP results exclude the impact of stock-based
compensation, restructuring, and additional depreciation expense. A
reconciliation of the adjustments made to GAAP net loss to compute non-GAAP
net loss is contained in the financial tables of this press release.
    "I am encouraged by our top-line results as we further penetrate top
tier accounts, and the analog market continues to improve. Our core power
business was up 28% in the quarter and interface was up 7.3%. The optics
business, which we have put into harvest mode, declined 41% to under $1
million," said Ralph Schmitt, CEO of Sipex. "We did not perform as well in
the gross margin area. The improvement in the market drove more commodity
business at lower margins. We also had a significant impact due to foundry
startup yield issues which now have been resolved."
    "There has been an intense focus on reducing our higher cost
inventories, and we made a significant impact in the quarter. Our inventory
levels are now at $11.4 million. On a unit basis, we have reduced our
inventory over 53 million units in the first half of this year. This is an
important activity in order for us to get to the lower cost material at the
foundries that will drive our gross margin improvement."
    "Sipex's improved delivery of new products continues with the
introduction of 8 new products in the second quarter. Most notable were the
completion of the 4.5V to 30V family of highly integrated DC-to-DC Buck
Controllers that continue to move Sipex up the value added proprietary
product curve," described Mr. Schmitt. "Sipex lighting solutions have
continued to expand significantly. We now have a simple 2 channel device
for low end mobile platforms all the way to a system level, 7-channel
product for feature rich handsets."
    "We hit a significant milestone in July by being listed on the NASDAQ
Global Market. This is a major step in our continuing improvement of
Sipex," explained Ray Wallin, CFO of Sipex. "Operating expenses increased
in the quarter due primarily to $1.4 million of one-time merger related
costs. Cost reductions have continued on an operating basis to bring our
operating expenses slightly below $9 million per quarter excluding stock
compensation expense and one-time merger related costs."
    Mr. Wallin continued, "We expect our revenues and margins to improve in
the third fiscal quarter. We have decided to forego a conference call due
to the pending merger with Exar."
    About Sipex Corporation
    Sipex Corporation is an analog semiconductor company that addresses
standard linear and application specific standard products (ASSP) for
customer systems that are primarily targeted at the consumer, networking
and industrial markets. Our products are categorized into three synergistic
areas of power management, interface and optical storage. Sipex is a global
company with operations in Asia, Europe and North America. It is the
mission of the Company to create innovative analog products that enable
customers to produce differentiated products.
    For further information, contact Ray Wallin at: Sipex Corporation, 233
South Hillview Drive, Milpitas, California 95035, (408) 934-7500; or visit
our website at http://www.sipex.com.
    Safe Harbor Statement
    This press release contains forward-looking statements concerning
Sipex's future events and results of operations including, but not limited
to statements about improvements in the analog market, the decline of the
optics business, improvements in gross margin and revenues and the pending
merger with Exar Corporation. Statements regarding the Company's beliefs,
plans, expectations or intentions regarding the future are forward-looking
statements, within the meaning of Section 27A of the Securities Act of
1933, as amended, and Section 21E of the Securities Exchange Act of 1934,
as amended. All such forward-looking statements are made pursuant to the
safe harbor provisions of the Private Securities Litigation Reform Act of
1995. These forward-looking statements are predictions and involve risks
and uncertainties, such that actual results may differ significantly. These
risks include, but are not limited to, the risk that Sipex may be unable to
execute operational improvements, that revenue from our optical business
may decline more than expected, that Sipex may not be able to appropriately
manage inventory levels, that the demand for analog products may not be as
expected, that general market conditions in the semiconductor industry may
decline, and that proposed merger Exar does not close as expected. The
Company disclaims any intention or obligation to publicly update or revise
any forward-looking statements, whether as a result of events or
circumstances after the date hereof or to reflect the occurrence of
unanticipated events. For further discussion of these risks and
uncertainties, we refer you to the documents the Company files with the SEC
from time to time, including the Company's Annual Report on Form 10-K for
the year ended December 30, 2006 and its Quarterly Report of Form 10-Q for
the quarters ended March 31, 2007 and June 30, 2007. All forward-looking
statements are made as of today, and the Company disclaims any duty to
update such statements.
    Non-GAAP Reporting -- The Company's management uses non-GAAP measures
to evaluate the performance of our business and to estimate future
performance. Since management finds this measure to be useful, we believe
that our investors benefit from seeing our results "through the eyes" of
management in addition to seeing our GAAP results. For comparison purposes,
the Company makes reference to certain gross margin, operating margin, net
loss and net loss per share. These non-GAAP results were reached by
excluding stock-based compensation expense, restructuring, and additional
depreciation expense. We reference those results to allow a better
comparison of results in the current period to those in prior periods and
to provide meaningful insight to the Company's on-going operating
performance. We have reconciled such non-GAAP results to the most directly
comparable GAAP financial measures. Our reference to these non-GAAP results
should be considered in addition to results that are prepared under current
accounting standards but should not be considered a substitute for results
that are presented as consistent with GAAP. It should also be noted that
our non-GAAP information may be different from the non-GAAP information
provided by other companies.
    Additional Information and Where You Can Find It
    Exar filed a Registration Statement on Form S-4 containing a proxy
statement / prospectus and other documents concerning the proposed merger
transaction with the Securities and Exchange Commission (the "SEC").
Security holders are urged to read the proxy statement/prospectus and other
relevant documents filed with the SEC because they will contain important
information. Security holders may obtain a free copy of the proxy
statement/prospectus (when it is available) and other documents filed by
Exar and Sipex with the SEC at the SEC's web site at http://www.sec.gov.
The proxy statement/prospectus and other documents may also be obtained for
free by contacting Exar Investor Relations by e-mail at
investorrelations@Exar.com or by telephone at 1-510-668-7201 or by
contacting Sipex Investor Relations by e-mail at
investorrelations@Sipex.com or by telephone at 1-408-934-7586.
    Exar and its executive officers and directors may be deemed to be
participants in the solicitation of proxies from Exar's stockholders with
respect to the transactions contemplated by the merger agreement.
Information regarding such executive officers and directors is included in
Exar's Proxy Statement for its 2006 Annual Meeting of Stockholders filed
with the SEC on August 9, 2006, which is available free of charge at the
SEC's web site at http://www.sec.gov and from Exar Investor Relations which
can be contacted by e-mail at investorrelations@Exar.com or by telephone at
1-510-668-7201. Certain executive officers and directors of Exar have
interests in the transaction that may differ from the interests of Exar
stockholders generally. These interests will be described in the proxy
statement/prospectus when it becomes available.
    Sipex and its executive officers and directors may be deemed to be
participants in the solicitation of proxies from Sipex's stockholders with
respect to the transactions contemplated by the merger agreement.
Information regarding such executive officers and directors is included in
Sipex's Proxy Statement for its 2006 Annual Meeting of Stockholders filed
with the SEC on October 24, 2006, which is available free of charge at the
SEC's web site at http://www.sec.gov and from Sipex Investor Relations
which can be contacted by e-mail at investorrelations@Sipex.com or by
telephone at 1-408-934-7586. Certain executive officers and directors of
Sipex have interests in the transaction that may differ from the interests
of Sipex stockholders generally. These interests will be described in the
proxy statement/prospectus when it becomes available.
                               SIPEX CORPORATION

                      Condensed Consolidated Balance Sheets
                                (In thousands)
                                 (Unaudited)


                                                  June 30,        December 30,
                                                    2007              2006
          ASSETS
          Current assets:
            Cash and cash equivalents               $2,845           $13,041
            Restricted cash                            -                 350
            Short-term investment
             securities                                597             2,388
            Accounts receivable, net                 5,427             6,222
            Accounts receivable, related
             party, net                              2,069               949
            Inventories, net                        11,356            15,586
            Prepaid expenses and other
             current assets                          1,914             1,641

                    Total current assets            24,208            40,177
          Property, plant and equipment,
           net                                      19,301            19,113
          Restricted cash - noncurrent                  58                57
          Other assets                                 204               202
          Total assets                             $43,771           $59,549

          LIABILITIES AND STOCKHOLDERS'
           DEFICIT
          Current liabilities:
            Current portion of long-term
             bank borrowing                           $667              $667
            Current portion of lease
             financing obligation                      220               191
            Accounts payable                         8,360            10,331
            Accrued expenses                         5,582             7,185
            Accrued restructuring costs                524             1,728
            Deferred income, related
             party                                   5,248             5,543
            Deferred income, other                   2,014             2,555

                    Total current liabilities       22,615            28,200

           Long-term portion of bank borrowing       1,000             1,333
           Long-term lease financing obligation     12,033            12,152
           Long-term accrued restructuring costs       -                 139
           Convertible senior notes                 26,224            25,826
           Other long-term liabilities                  22                24

                    Total liabilities               61,894            67,674

           Stockholders' deficit:
            Common stock                               190               184
            Additional paid-in capital             239,063           234,785
            Accumulated deficit                   (257,357)         (243,075)
            Accumulated other
             comprehensive loss                        (19)              (19)
                    Total stockholders'
                     deficit                       (18,123)           (8,125)
          Total liabilities and
           stockholders' deficit                   $43,771           $59,549




                              SIPEX CORPORATION
               Condensed Consolidated Statements of Operations
                    (In thousands, except per share data)
                                 (Unaudited)


                                 For the Three Months      For the Six Months
                                        Ended                    Ended
                               June 30, March 31, July 1,  June 30,  July 1,
                                 2007     2007     2006      2007      2006

    Net sales                    $9,857   $8,758  $11,558   $18,615   $20,861
    Net sales, related party      8,562    8,101    9,455    16,663    18,006

            Total net sales      18,419   16,859   21,013    35,278    38,867

    Cost of sales                 8,177    7,073    9,781    15,250    19,959
    Cost of sales, related
     party                        6,241    5,347    7,366    11,588    15,237

            Total cost of sales  14,418   12,420   17,147    26,838    35,196
            Gross profit          4,001    4,439    3,866     8,440     3,671

    Operating expenses:
      Research and development    3,431    3,686    3,883     7,117     9,379
      Marketing and selling       3,115    3,293    3,765     6,408     7,421
      General and
       administrative             4,650    2,968    2,743     7,617     6,764
      Restructuring and other      (103)      63      (22)      (40)      285
            Total operating
             expenses            11,093   10,010   10,369    21,102    23,849
    Loss from operations         (7,092)  (5,571)  (6,503)  (12,662)  (20,178)
    Other income (expense):
      Interest income                60      131      221       191       270
      Interest expense             (897)    (834)    (582)   (1,731)     (765)
      Other income, net             -          1       59       -         101
         Total other expense, net  (837)    (702)    (302)   (1,540)     (394)

    Loss before income tax
     expense                     (7,929)  (6,273)  (6,805)  (14,202)  (20,572)
    Income tax expense               51       17       53        68        85
    Net loss                    $(7,980) $(6,290) $(6,858) $(14,270) $(20,657)

    Net loss per common share    $(0.42)  $(0.34)  $(0.39)   $(0.76)   $(1.16)
       - basic and diluted
    Weighted average common
      shares outstanding
       - basic and diluted       18,798   18,547   17,775    18,673    17,775



                              SIPEX CORPORATION
     Reconciliation of GAAP Gross Profit (Loss) to Non-GAAP Gross Profit
                                    (Loss)
                                (In thousands)
                                 (Unaudited)


                                  For the Three Months     For the Six Months
                                         Ended                   Ended
                                   June 30, March 31, July 1, June 30, July 1,
                                     2007     2007     2006     2007     2006

     GAAP - gross profit            $4,001   $4,439   $3,866   $8,440   $3,671

         Increased depreciation due
          to shorter economic
         life of Hillview facility
          included in:
             Total cost of sales       -         -        -       -      4,519

         Stock-based compensation
          included in:
             Total cost of sales       124      111      (59)     235       68

     Non-GAAP - gross profit        $4,125   $4,550   $3,807   $8,675   $8,258

    GAAP gross profit as a
      percent of net sales             22%      26%      18%      24%       9%

    Non-GAAP gross profit as a
      percent of net sales             22%      27%      18%      25%      21%



                              SIPEX CORPORATION
 Reconciliation of GAAP Loss from Operations to Non-GAAP Loss from Operations
                                (In thousands)
                                 (Unaudited)


                               For the Three Months         For the Six Months
                                      Ended                       Ended
                               June 30, March 31, July 1,   June 30,   July 1,
                                 2007     2007     2006      2007       2006

     GAAP - loss from
      operations              $(7,092) $(5,571) $(6,503)  $(12,662) $(20,178)

         Increased depreciation
          due to shorter
          economic
         life of Hillview
          facility included in:
             Total cost of
              sales                -        -        -         -       4,519
             Research and
              development          -        -        -         -       1,118
             Marketing and
              selling              -        -        -         -         322
             General and
              administrative       -        -        -         -         744

         Stock-based compensation
          included in:
               Total cost of
                sales             124      111      (59)      235         68
               Research and
                development       142      231      311       373        649
               Marketing and
                selling           242      258      235       499        425
               General and
                administrative    424      304      309       729        587

         Restructuring and
          other                  (103)      63      (22)      (40)       285

     Non-GAAP - loss from
      operations               $(6,263) $(4,604) $(5,729) $(10,866) $(11,461)



                              SIPEX CORPORATION
             Reconciliation of GAAP Net Loss to Non-GAAP Net Loss
                                (In thousands)
                                 (Unaudited)


                                 For the Three Months      For the Six Months
                                        Ended                    Ended
                               June 30, March 31, July 1,  June 30,  July 1,
                                 2007     2007     2006      2007      2006

     GAAP - Net loss           $(7,980) $(6,290) $(6,858) $(14,270) $(20,657)

         Increased depreciation
          due to shorter
          economic
         life of Hillview
          facility included in:
             Total cost of sales   -        -        -         -       4,519
             Research and
              development          -        -        -         -       1,118
             Marketing and
              selling              -        -        -         -         322
             General and
              administrative       -        -        -         -         744

         Stock-based compensation
          included in:
             Total cost of sales   124      111      (59)      235        68
             Research and
              development          142      231      311       373       649
             Marketing and
              selling              242      258      235       499       425
             General and
              administrative       424      304      309       729       587

         Restructuring and
          other                   (103)      63      (22)      (40)      285

     Non-GAAP - Net loss       $(7,151) $(5,323) $(6,084) $(12,474) $(11,940)



                              SIPEX CORPORATION
   Reconciliation of GAAP Net Loss Per Share to Non-GAAP Net Loss Per Share
                    (In thousands, except per share data)
                                 (Unaudited)


                                     For the Three Months   For the Six Months
                                             Ended                Ended
                                   June 30, March 31, July 1, June 30, July 1,
                                      2007   2007      2006    2007    2006

     GAAP - Net loss per share       $(0.42) $(0.34)  $(0.39) $(0.76) $(1.16)

         Increased depreciation due
          to shorter economic
         life of Hillview facility
          included in:
             Total cost of sales        -       -       -       -       0.25
             Research and development   -       -       -       -       0.06
             Marketing and selling      -       -       -       -       0.02
             General and
              administrative            -       -       -       -       0.04

         Stock-based compensation
          included in:
             Total cost of sales       0.01    0.01    (0.00)   0.01    0.00
             Research and development  0.01    0.01     0.02    0.02    0.04
             Marketing and selling     0.01    0.01     0.01    0.03    0.02
             General and
              administrative           0.02    0.02     0.02    0.04    0.03

         Restructuring and other      (0.01)   0.00    (0.00)  (0.00)   0.02

     Non-GAAP - Net loss per share
      (1)                            $(0.38) $(0.29)  $(0.34) $(0.67) $(0.67)

    Weighted average common shares
     outstanding - basic
     and diluted                     18,798  18,547   17,775  18,673  17,775

       (1)  Amounts may not aggregate to the total due to rounding


SOURCE Sipex Corp.




Back to Topback to top

Related links:
  • http://www.sipex.com
  • http://www.prnewswire.com/comp/111683.html/
    CONTACT:
    Clyde Ray Wallin, Chief Financial Officer of
    Sipex Corp., +1-408-934-7500, fax, +1-408-935-7678,
    rwallin@sipex.com